We have 4 of 212 papers
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
In the version of the article initially published, the graphs in Fig. 2a were missing and have now been reinserted in the HTML and PDF versions of the article.
An in-cell method that sensitively detects rare off-target edits, benchmarks performance across editors, and improves risk assessment in therapeutic cells is presented, establishing UNCOVERseq as a robust framework for informed off-target risk assessment in translational gene-editing systems.
It is shown that off-target editing and translocations vary widely between individual cells and organs, motivating the development of more sensitive and organ-specific safety assays for CRISPR therapies.
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.
